Valuation (28%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 1,309.47 | 28.83 |
| PEG Ratio (TTM) | 23.88 | 12.49 |
| P/S Ratio (TTM) | 0.26 | 11.88 |
| P/B Ratio (TTM) | 0.20 | 24.73 |
| P/FCF Ratio (TTM) | N/A | 25.07 |
| Price to 5YR AVG Earnings Ratio | N/A | 36.68 |
| Price to 5YR AVG FCF Ratio | N/A | 31.49 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.01% | 15.42% |
| ROE (TTM) | 0.02% | 71.02% |
| Net Profit Margin (TTM) | 0.02% | 36.57% |
| ROIC 5YR AVG | N/A | 46.37% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -102.57% | -31.51% | N/A |
| Revenue | -0.72% | -15.20% | N/A |
| Net Income | -100.91% | -32.37% | N/A |
| Cash Flow | -18,055.96% | -101.11% | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.72 | 1.98 |
| Quick Ratio (TTM) | 1.72 | 1.98 |
| D/E Ratio (TTM) | 0.57 | 1.61 |
| Interest Coverage (TTM) | 6.89 | 21.33 |
| Piotroski F-Score | 2 | 7 |
| Altman Z-Score | N/A | 6.38 |
| LTL to 5YR AVG FCF | N/A | 3.50 |
| Shares Outstanding Growth 5YR AVG | N/A | 58.76% |